GoCART

Website
BioTech,DeepTech,HealthTech

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Henry Erdlei, Chase Blakeley
Pre-Seed
United States
BioTech, DeepTech, HealthTech
GoCART follows a platform licensing and co-development model. We aim to advance one lead program in AML and MM to clinical appoval of the platform, while partnering additional indications with biotech/pharma companies using our universal CAR trunk architecture. The modular binder system enables a scalable pipeline with lower marginal development costs per indication. There will be cell products and viral vectors exclusively sold by us and target specific binder peptides, sometimes sold by us directly but maily by collaborators that want to use our platform architecture. For those, we charge a comission.

GoCART is a pre-seed biopharma company building a modular System for "AND"-Gated CAR T-cell therapy. Ends the "undruggable target" problem and reaches the 70% of cancers without specific treatment option. Aiming at AML and Multiple Myeloma as Beachheads